GlassScriptPhysician profile
Heather M Fogle
NPI 1689219768
$1,317.92
in general payments reported to CMS, 2019-2025
20 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.00 · 2022: $318 · 2023: $376 · 2024: $338 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $942.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $248.87 | 2022-2025 | |
| Lilly USA, LLC | $175.90 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $167.50 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Teva Pharmaceuticals USA, INC. | $105.68 | 2022-2024 | Austedo Xr, Uzedy |
| Antares Pharma, INC. | $101.50 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Gilead Sciences, INC. | $97.53 | 2021-2025 | Descovy |
| Otsuka America Pharmaceutical, INC. | $97.29 | 2021-2025 | Rexulti |
| Pfizer INC. | $72.78 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.73 | 2022-2024 | Jardiance |
| Braeburn INC. | $29.59 | 2024 | Brixadi |
| Seqirus USA INC | $28.04 | 2024 | Fluad, Flucelvax |
| Alkermes, INC. | $25.82 | 2023 | Vivitrol |
| Merck Sharp & Dohme LLC | $23.87 | 2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Organon LLC | $22.27 | 2023 | Nexplanon |
| Halozyme INC | $17.83 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $17.29 | 2024 | Thinprep 2000 Processor, Aptima |
| Janssen Pharmaceuticals, INC | $14.59 | 2022 | |
| Lundbeck LLC | $14.03 | 2025 | Rexulti |
| Exact Sciences Corporation | $13.54 | 2023 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Fogle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.